|
1.
|
|
11 p, 1.1 MB |
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality
/
Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ;
Lassus, Johan (Helsinki University Hospital) ;
Varpula, Marjut (Helsinki) ;
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ;
Sund, Reijo (Helsinki) ;
Køber, Lars (Rigshospitalet) ;
Spinar, Jindrich (University Hospital Brno (República Txeca)) ;
Parissis, John (University General Hospital Attikon (Haidari, Grècia)) ;
Banaszewski, Marek (Institute of Cardiology) ;
Silva Cardoso, Jose (University of Porto) ;
Carubelli, Valentina (University and Civil Hospital of Brescia) ;
Di Somma, Salvatore (University of Rome Sapienza) ;
Mebazaa, Alexandre (Hopital Lariboisiere) ;
Harjola, Veli-Pekka (University of Helsinki) ;
Kober, Lars ;
Koniari, Katerina ;
Voumvourakis, Astrinos ;
Karavidas, Apostolos ;
Sans-Rosello, Jordi ;
Vila, Montserrat ;
Duran-Cambra, Albert ;
Metra, Marco ;
Bulgari, Michela ;
Lazzarini, Valentina ;
Parenica, Jiri ;
Stipal, Roman ;
Ludka, Ondrej ;
Palsuva, Marie ;
Ganovska, Eva ;
Kubena, Petr ;
Lindholm, Matias G. ;
Hassager, Christian ;
Bäcklund, Tom (Helsinki) ;
Jurkko, Raija (Helsinki) ;
Järvinen, Kristiina (Helsinki) ;
Nieminen, Tuomo (Helsinki) ;
Pulkki, Kari (Helsinki University Hospital (Finlàndia)) ;
Soininen, Leena (Helsinki) ;
Tierala, Ilkka (Helsinki) ;
Tolonen, Jukka (Helsinki) ;
Korva, Tuomas (Helsinki) ;
Pitkälä, Anne (Helsinki) ;
Marino, Rossella ;
Sousa, Alexandra ;
Sousa, Carla ;
Paiva, Mariana ;
Rangel, Inés ;
Almeida, Rui ;
Pinho, Teresa ;
Maciel, Maria Júlia ;
Stepinska, Janina ;
Skrobisz, Anna ;
Góral, Piotr ;
Universitat Autònoma de Barcelona
Vasopressors and inotropes remain a cornerstone in stabilization of the severely impaired hemodynamics and cardiac output in cardiogenic shock (CS). The aim of this study was to analyze current real-life use of these medications, and their impact on outcome and on changes in cardiac and renal biomarkers over time in CS. [...]
2016 -  10.1186/s13054-016-1387-1
Critical Care, Vol. 20 Núm. 1 (april 2016) , p. 208
|
|
|
2.
|
|
15 p, 1.8 MB |
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock
/
Jäntti, Toni (Helsinki University Hospital (Finlàndia)) ;
Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ;
Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ;
Pulkki, Kari (Helsinki University Hospital (Finlàndia)) ;
Turkia, Heidi (Helsinki University Hospital (Finlàndia)) ;
Sabell, Tuija (Helsinki University Hospital (Finlàndia)) ;
Tolppanen, Heli (Helsinki University Hospital (Finlàndia)) ;
Jurkko, Raija (Helsinki University Hospital (Finlàndia)) ;
Hongisto, Mari (Helsinki University Hospital (Finlàndia)) ;
Kataja, Anu (Helsinki University Hospital (Finlàndia)) ;
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ;
Silva-Cardoso, Jose (University of Porto) ;
Banaszewski, Marek (National Institute of Cardiology, Warsaw, Poland) ;
DiSomma, Salvatore (University of Rome Sapienza) ;
Mebazaa, Alexandre (University Paris Diderot) ;
Haapio, Mikko (Helsinki University Hospital (Finlàndia)) ;
Lassus, Johan (Helsinki University Hospital (Finlàndia)) ;
Universitat Autònoma de Barcelona
Acute kidney injury (AKI) is a frequent form of organ injury in cardiogenic shock. However, data on AKI markers such as plasma proenkephalin (P-PENK) and neutrophil gelatinase-associated lipocalin (P-NGAL) in cardiogenic shock populations are lacking. [...]
2021 - 10.1186/s13613-021-00814-8
Annals of Intensive Care, Vol. 11 (february 2021)
|
|
|
3.
|
|
8 p, 99.6 KB |
Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin : educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)
/
Saenger, Amy K. (University of Minnesota. Department of Laboratory Medicine and Pathology) ;
Jaffe, Allan S. (Mayo Clinic. Department of Laboratory Medicine and Pathology and Cardiology) ;
Body, Richard (Manchester University NHS Foundation Trust. Healthcare Sciences Department) ;
Collinson, Paul O. (St George's University Hospitals NHS Foundation Trust. Department of Clinical Blood Sciences and Cardiology) ;
Kavsak, Peter A. (McMaster University. Department of Pathology and Molecular Medicine) ;
Lam, Carolyn S. P. (Duke-National University of Singapore) ;
Lefèvre, Guillaume (Hospital Tenon. Service de Biochimie-Hormonologie) ;
Omland, Tobjørn (Akershus University Hospital) ;
Ordoñez Llanos, Jorge 1952- (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Pulkki, Kari (University of Turku. Department of Clinical Chemistry) ;
Apple, Fred S. (University of Minnesota. Department of Laboratory Medicine and Pathology)
Two interferences recently brought to the forefront as patient safety issues include hemolysis (hemoglobin) and biotin (vitamin B7). The International Federation for Clinical Chemistry Committee on Cardiac Biomarkers (IFCC-CB) obtained input from a majority of cTn and NP assay manufacturers to collate information related to high-sensitivity (hs)-cTnI, hs-cTnT, contemporary, and POC cTn assays, and NP assays interferences due to hemolysis and biotin. [...]
2019 - 10.1515/cclm-2018-0905
Clinical Chemistry and Laboratory Medicine, Vol. 57, issue 5 (2019) , p. 633-640
|
|
|
4.
|
|
14 p, 796.0 KB |
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock
/
Jäntti, Toni (Helsinki University Hospital (Finlàndia)) ;
Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ;
Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ;
Parissis, J. (University General Hospital Attikon (Haidari, Grècia)) ;
Pulkki, Kari (Turku University Hospital (Finlàndia)) ;
Javanainen, T. (Helsinki University Hospital (Finlàndia)) ;
Tolppanen, H. (Helsinki University Hospital (Finlàndia)) ;
Jurkko, Raija (Helsinki University Hospital (Finlàndia)) ;
Hongisto, Mari (Helsinki University Hospital (Finlàndia)) ;
Kataja, Anu (Helsinki University Hospital (Finlàndia)) ;
Sionis, A. (Institut d'Investigació Biomèdica Sant Pau) ;
Silva-Cardoso, J. (Department of Cardiology. CINTESIS. Porto Medical School. São João Hospital Center. University of Porto) ;
Banaszewski, Marek (Intensive Cardiac Therapy Clinic. Institute of Cardiology) ;
Spinar, J. (University Hospital Brno (República Txeca)) ;
Mebazaa, Alexandre (INSERM U942. University Paris Diderot. Department of Anesthesia and Critical Care. Hôpital Lariboisière. APHP) ;
Lassus, J. (Helsinki University Hospital (Finlàndia)) ;
Universitat Autònoma de Barcelona
Introduction The prevalence of hypoalbuminemia, early changes of plasma albumin (P-Alb) levels, and their effects on mortality in cardiogenic shock are unknown. Materials and methods P-Alb was measured from serial blood samples in 178 patients from a prospective multinational study on cardiogenic shock. [...]
2019 - 10.1371/journal.pone.0217006
PloS one, Vol. 14 Núm. 5 (may 2019) , p. e0217006
|
|
|
5.
|
|
5 p, 173.0 KB |
Circulating levels of 423-5p are associated with 90 day mortality in cardiogenic shock
/
Jäntti, Toni (Helsinki University Hospital (Finlàndia)) ;
Segersvärd, Heli (Minerva Foundation Institute for Medical Research and University of Helsinki) ;
Tolppanen, Heli (Helsinki University Hospital (Finlàndia)) ;
Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ;
Lassus, Johan (Helsinki University Hospital (Finlàndia)) ;
Devaux, Yvan (Luxembourg Institute of Health) ;
Vausort, Mélanie (Luxembourg Institute of Health) ;
Pulkki, Kari (Department of Clinical Chemistry, University of Eastern Finland and Eastern Finland Laboratory Centre (ISLAB)) ;
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Tikkanen, Ilkka (Helsinki University Hospital (Finlàndia)) ;
Lakkisto, Päivi (Helsinki University Hospital (Finlàndia)) ;
Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
The role of microRNAs has not been studied in cardiogenic shock. We examined the potential role of miR-423-5p level to predict mortality and associations of miR-423-5p with prognostic markers in cardiogenic shock. [...]
2018 - 10.1002/ehf2.12377
ESC Heart Failure, Vol. 6 (november 2018) , p. 98-102
|
|
|
6.
|
|
10 p, 989.2 KB |
Adrenomedullin : a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
/
Tolppanen, Heli (Helsinki University Hospital (Finlàndia)) ;
Rivas-Lasarte, Mercedes (Institut d'Investigació Biomèdica Sant Pau) ;
Lassus, Johan (Helsinki University Hospital (Finlàndia)) ;
Sans-Roselló, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Hartmann, Oliver (Sphingotec GmbH, Hennigsdorf, Germany) ;
Lindholm, Matias (Copenhagen University Hospital Rigshospitalet) ;
Arrigo, Mattia (University Hospital Zurich (Suïssa)) ;
Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ;
Köber, Lars (Copenhagen University Hospital Rigshospitalet) ;
Thiele, Holger (Universitätsklinikum Schleswig-Holstein (Alemanya)) ;
Pulkki, Kari (Eastern Finland Laboratory Centre) ;
Spinar, Jindrich (International Clinical Research Centre (ICRC), Brno, Czech Republic) ;
Parissis, John (University General Hospital Attikon (Haidari, Grècia)) ;
Banaszewski, Marek (Intensive Cardiac Therapy Clinic, Institute of Cardiology, Warsaw, Poland) ;
Silva-Cardoso, Jose (Department of Cardiology, CINTESIS, Porto Medical School, São João Hospital Center, University of Porto) ;
Carubelli, Valentina (Division of Cardiology, Department of Medical and Surgical Specialties Radiological Sciences and Public Health, University and Civil Hospital of Brescia) ;
Sionis, Alessandro (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ;
Mebazaa, Alexandre (Université Paris Diderot) ;
Universitat Autònoma de Barcelona
The clinical CardShock risk score, including baseline lactate levels, was recently shown to facilitate risk stratification in patients with cardiogenic shock (CS). As based on baseline parameters, however, it may not reflect the change in mortality risk in response to initial therapies. [...]
2017 - 10.1186/s13613-016-0229-2
Annals of Intensive Care, Vol. 7 (january 2017)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
